Quick Answer
Apyx Medical Corp reported Total Revenue of $52.35 million for fiscal year 2023.
Apyx Medical Corp — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Revenue | — | — | $52.35M +17.6% |
$44.51M -8.3% |
$48.52M +75.1% |
$27.71M -1.9% |
| Revenue (ASC 606) | — | — | $52.35M +17.6% |
$44.51M -8.3% |
$48.52M +75.1% |
$27.71M -1.9% |
| Net Income | -$11.21M +52.2% |
-$23.46M -25.4% |
-$18.71M +19.3% |
-$23.18M -52.8% |
-$15.17M -27.5% |
-$11.90M +39.6% |
| Diluted EPS | — | — | -$0.54 +19.4% |
-$0.67 -52.3% |
-$0.44 -25.7% |
-$0.35 +39.7% |
| Total Assets | $66.84M +3.1% |
$64.84M -18.2% |
$79.24M +53.0% |
$51.77M -24.7% |
$68.72M -7.3% |
$74.11M -19.3% |
| Cash and Equivalents | $31.74M -0.0% |
$31.74M -27.3% |
$43.65M +328.3% |
$10.19M -67.0% |
$30.87M -26.4% |
$41.91M +29.3% |
| Long-Term Debt | $34.85M +2.8% |
$33.89M +2.1% |
$33.19M | $0.00 | — | — |
| Stockholders Equity | $14.54M +2.3% |
$14.21M -46.8% |
$26.70M -29.0% |
$37.58M -30.0% |
$53.70M -15.7% |
$63.72M -23.1% |
| R&D Expense | $3.37M -33.6% |
$5.08M -6.6% |
$5.44M +19.7% |
$4.54M +5.2% |
$4.32M +10.2% |
$3.92M +5.1% |
| Operating Income | -$6.45M +65.8% |
-$18.84M -9.2% |
-$17.26M +26.8% |
-$23.56M -63.1% |
-$14.45M +28.1% |
-$20.08M +3.8% |
| Gross Profit | $33.04M +12.5% |
$29.36M -13.0% |
$33.76M +15.9% |
$29.13M -13.3% |
$33.60M +92.0% |
$17.50M -8.3% |
| Shares Outstanding | 41.79M +10.6% |
37.79M +9.1% |
34.64M +0.1% |
34.60M +0.5% |
34.41M +0.4% |
34.29M +1.2% |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Total Revenue | June 30, 2024 | $12.15M | -10.5% | +18.6% |
| Revenue (ASC 606) | June 30, 2024 | $12.15M | -10.5% | +18.6% |
| Net Income | September 30, 2025 | -$1.98M | +57.8% | +47.5% |
| Diluted EPS | June 30, 2024 | -$0.19 | -533.3% | +13.6% |
| Total Assets | September 30, 2025 | $57.37M | -5.5% | -1.4% |
| Cash and Equivalents | September 30, 2025 | $25.14M | -10.3% | -14.2% |
| Long-Term Debt | September 30, 2025 | $34.61M | +2.2% | +0.7% |
| Stockholders Equity | September 30, 2025 | $5.85M | -47.0% | -19.4% |
| R&D Expense | September 30, 2025 | $801.0K | -29.9% | -2.8% |
| Operating Income | September 30, 2025 | -$832.0K | +77.1% | +67.7% |
| Gross Profit | September 30, 2025 | $8.30M | +19.3% | +17.1% |
| Shares Outstanding | September 30, 2025 | 37.82M | +9.2% | +0.1% |
- Apyx Medical Corp reported Total Revenue of $52.35 million for fiscal year 2023.
- Apyx Medical Corp showed an increase of +17.6% in Total Revenue compared to the prior fiscal year.
- Apyx Medical Corp reported Revenue (ASC 606) of $52.35 million for fiscal year 2023.
- Apyx Medical Corp showed an increase of +17.6% in Revenue (ASC 606) compared to the prior fiscal year.
- Apyx Medical Corp reported Net Income of -$11.21 million for fiscal year 2025.
- Apyx Medical Corp showed an increase of +52.2% in Net Income compared to the prior fiscal year.
- Apyx Medical Corp reported Diluted EPS of $0.54 per share (loss) for fiscal year 2023.
- Apyx Medical Corp showed an increase of +19.4% in Diluted EPS compared to the prior fiscal year.
- Apyx Medical Corp reported Total Assets of $66.84 million for fiscal year 2025.
- Apyx Medical Corp showed an increase of +3.1% in Total Assets compared to the prior fiscal year.
- Apyx Medical Corp reported Cash and Equivalents of $31.74 million for fiscal year 2025.
- Apyx Medical Corp showed a decrease of -0.0% in Cash and Equivalents compared to the prior fiscal year.
- Apyx Medical Corp reported Long-Term Debt of $34.85 million for fiscal year 2025.
- Apyx Medical Corp showed an increase of +2.8% in Long-Term Debt compared to the prior fiscal year.
- Apyx Medical Corp reported Stockholders Equity of $14.54 million for fiscal year 2025.
- Apyx Medical Corp showed an increase of +2.3% in Stockholders Equity compared to the prior fiscal year.
- Apyx Medical Corp reported R&D Expense of $3.37 million for fiscal year 2025.
- Apyx Medical Corp showed a decrease of -33.6% in R&D Expense compared to the prior fiscal year.
- Apyx Medical Corp reported Operating Income of -$6.45 million for fiscal year 2025.
- Apyx Medical Corp showed an increase of +65.8% in Operating Income compared to the prior fiscal year.
- Apyx Medical Corp reported Gross Profit of $33.04 million for fiscal year 2025.
- Apyx Medical Corp showed an increase of +12.5% in Gross Profit compared to the prior fiscal year.
- Apyx Medical Corp reported Shares Outstanding of 41.79 million shares for fiscal year 2025.
- Apyx Medical Corp showed an increase of +10.6% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: